Imaging firms hit by declining earnings

Article

The medical imaging device segment was one of the worst performing sectors in the healthcare industry during the second quarter of 1998, with earnings dropping 14.5% despite a revenue increase of 6.8%, according to a report produced by KPMG’s Health

The medical imaging device segment was one of the worst performing sectors in the healthcare industry during the second quarter of 1998, with earnings dropping 14.5% despite a revenue increase of 6.8%, according to a report produced by KPMG’s Health Care Transaction Services division and WDI Healthcare Markets Group. Only the durable medical equipment and monitoring devices segments posted lower results, with earnings for those sectors dropping 28.2% and 36.8%, respectively.

For imaging device companies, the quarter continues a reduced profitability trend that has plagued the sector in recent periods. In the first quarter of this year, earnings decreased 1.9% with a 10.5% increase in revenue, according to KPMG and WDI, which is based in Hilton Head, SC. Fourth-quarter earnings were down 15.2% despite a 9.6% increase in revenue.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.